Company

Mammoth Biosciences Inc.

Biotech developing CRISPR-based detection tools and gene-editing therapeutics, founded in 2017 by Jennifer Doudna and colleagues.

About

Mammoth Biosciences Inc. develops CRISPR-based platforms for disease detection and for in vivo gene-editing therapeutics. Founded in 2017 by Ashley Tehranchi, Janice Chen, Jennifer Doudna, Lucas Harrington and Trevor Martin, and based in California, US, the company had over 100 employees as of September 2021. In September 2021 it received USD 150 million led by Redmile Group, with participation from Foresite Capital, Sixth Street, Mayfield and others.

6Funding rounds

15Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in